Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Lung Cancer
Both
Lung Cancer
Trial Information
Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"
Inclusion Criteria:
- History squamous cell NSCLC who have undergone complete resection or definitive
chemotherapy
Exclusion Criteria:
- History of an aerodigestive tract carcinoma of non-squamous histology
- Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have
undergone resection or chemotherapy within three years
- Patients who have Stage I or II squamous cell lung cancer that have undergone
resection or chemotherapy within one year
- Patients who have received external beam radiation therapy for treatment of a
squamous cell cancer of the lung
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Tracey Weigel, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Wisconsin Medical School
Authority:
United States: Institutional Review Board
Study ID:
2001-431
NCT ID:
NCT00205439
Start Date:
December 2001
Completion Date:
Related Keywords:
- Lung Cancer
- Carcinoma, Squamous Cell
- Lung Neoplasms
Name | Location |
|---|---|
| University of Wisconsin Hospital and Clinics | Madison, Wisconsin 53792-0001 |
